v3 Template
I

Impact BioMedical Inc.

Biotechnology Houston, TX, USA ~260 employees
Founded
--
Employees (Est.)
~260
13 leaders known
Total Funding
$9.0M
Funding Rounds
2
Last Funding
2024-09-16

About Impact BioMedical Inc.

Impact Biomedical, Inc. is a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions inspired by nature and powered by science, with a mission to advance human wellness.

Products & Services

Linebacker™:A platform using small molecule X-bonded polyphenols to potentially improve potency, efficacy, bioavailability, and permeability of biopharmaceuticals while ensuring safety and tolerability.
Laetose™:A unique combination of multiple sugars paired with inositol to potentially inhibit inflammatory and metabolic responses of sugar alone.
3F™:A unique formulation of botanical ingredients (e.g., terpenes) with demonstrated effects as an insect repellent and antimicrobial.
Equivir™:A novel FDA Generally Recognized as Safe (GRAS) eligible polyphenol blend with proven antiviral effects and potential applications as medication or supplements.
Celios(r):An advanced air purification technology committed to improving indoor air quality through patented filtration solutions.

Specialties

Healthcare solutions Biopharmaceuticals Antiviral technologies Air purification Botanical formulations

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: IPO
T: -
FT: IPO
A: 4500000
MR: -
FA: $4,500,000
FAN: 4500000
D: 2024-09-16
FD: 2024-09-16
1 investors
2 RT: Initial Public Offering
T: -
FT: Initial Public Offering
A: 4500000
MR: -
FA: 1,500,000 shares at $3.00 per share
FAN: 4500000
D: 2024-09-16
FD: 2024-09-16
1 investors
IPO Latest
2024-09-16
$4.5M
1 investor (Pro only)
Initial Public Offering 2024-09-16
$4.5M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

F

Frank D. Heuszel, Esq.

Chairman of the Board and Chief Executive Officer

M

Mark Suseck

Chief Operating Officer

M

Mark Susek

Chief Operating Officer

T

Todd Macko

Chief Financial Officer

C

Castel Hibbert

C

Chris Zimmerman

View 10 more team members with Pro

Unlock Full Team Directory

Recent News

Impact BioMedical Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~260 employees (est.)
Locations
Houston, TX, USA

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro